IPRs and Technological Development in Pharmaceuticals

The Development Agenda: Global Intellectual Property and Developing Countries

Volumn , Issue , 2009, Pages

  Laforgia, Francesco ^a,b   Montobbio, Fabio ^b,c   Orsenigo, Luigi ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b BOCCONI UNIVERSITY   (Italy)

^c UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Brazil; Developing countries; Drugs; Innovation; Intellectual property; IPR; Patent; Pharmaceutical; TRIPS

Indexed keywords

EID: 84921577747     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780195342109.003.0013     Document Type: Chapter

References (75)

1. Acemoglu, Daron, and Joshua Linn. 2004. Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry. Quarterly Journal of Economics 119(3): 1049-90.
2. Adelman, Martin J. 1987. The New World of Patents Created by the Court of Appeals for the Federal Circuit. University of Michigan Journal of Law Reform 20: 979-1007.
3. Agrawal, Ajay, and Rebecca M. Henderson. 2002. Putting Patents in Context: Exploring Knowledge Transfer from MIT. Management Science 48: 44-60.
4. Albuquerque, Eduardo. 2000. Domestic Patents and Developing Countries:Argument for Their Study and Data from Brazil (1980-1995). Research Policy 29: 1047-60.
5. Arora, Ashish, Andrea Fosfuri, and Alfonso Gambardella. 2001. Markets for Technology: The Economics of Innovation and Corporate Strategy. Cambridge, MA: MIT Press.
6. Arora, Ashish, Marco Ceccagnoli, and Wesley M. Cohen. 2005. R&D and the Patent Premium. NBER Working Paper Series, No. 9431.
7. Arrow, Kenneth J. 1962. Economic Welfare and the Allocation of Resource for Invention. In Richard R. Nelson, ed., The Rate and Direction of Inventive Activity: Economic and Social Factors. Princeton: Princeton University Press for the NBER.
8. Azoulay, Pierre, Waverly Ding, and Toby Stuart. July 23, 2004. The Effect of Academic Patenting on (Public) Research Output. Academic Science and Entrepreneurship: Dual Engines of Growth? NBER Summer Institute. Cambridge, MA.
9. Baker, Dean, and Noriko Chatani. August 7, 2007. Promoting Good Ideas on Drugs: Are Patents the Best Way? Center for Economic and Policy Research; http://www.cepr.net/documents/publications/Promoting_Good_Ideas_on_Drugs.pdf.
10. Baumol, William J. 1990. Entrepreneurship: Productive, Unproductive and Destructive. The Journal of Political Economy 98(5): 893-921.
11. Bessen, James, and Erik Maskin. 2000. Sequential Innovation, Patents, and Imitation. Institute of Technology Massachusetts, Department of Economics. Working Paper No. 00-01.
12. Breschi, Stefano, Francesco Lissoni, and Fabio Montobbio. 2005. From Publishing to Patenting: Do Productive Scientists Turn Into Academic Inventors? Revue d'Economie Industrielle 110(2): 75-102.
13. Cadot, Oliver, and Steven A. Lippman. 1995. Barriers to Imitation and the Incentive to Innovate. Western Management Science Institute, University of California at Los Angeles. Working Paper No. 434.
14. Chaudhuri, Sudip. 2005. The WTO and India's Pharmaceutical Industry. Patent Protection, TRIPS and Developing Countries Oxford: New Delhi: Oxford University Press.
15. Cohen, Wesley M., Richard R. Nelson, and John P. Walsh. 2002. Links and Impacts: The Influence of Public Research on Industrial R&D. Management Science 48: 1-23.
16. Coriat, Benjamin, Fabienne Orsi, and Cristina d'Almeida. 2006. TRIPS and the International Public Health Controversies: Issues and Challenges. Industrial and Corporate Change 15(6): 1033-62.
17. Danzon, Patricia M. 1997. Pharmaceutical Price Regulation: National Policies versus Global Interests. Washington, DC: American Enterprise Institute Press.
18. Danzon, Patricia M., and Jeong Kim. 1998. International Price Comparisons for Pharmaceuticals: Measurement and Policy Issues. Pharmacoeconomics 14: 115-28.
19. Dasgupta, Partha, and Joseph E. Stiglitz. 1980a. Uncertainty, Industrial Structure, and the Speed of R&D. Bell Journal of Economics 11(1): 1-28.
20. Dasgupta, Partha, and Joseph E. Stiglitz. 1981. Entry, Innovation, Exit: Toward a Dynamic Theory of Oligopolistic Industrial Structure. European Economic Review 15(2): 137-58.
21. Dasgupta, Partha, Richard J. Gilbert, and Joseph E. Stiglitz. 1982. Invention and Innovation under Alternative Market Structures: The Case of Natural Resources. Review of Economic Studies 49(4): 567-82.
22. Deardorff, Alan V. 1992. Welfare Benefits of Global Patent Protection. Economica 59(233): 35-51.
23. FAPESP-The State of São Paulo Research Foundation. 2005. Patenting Activity in Brazil and Abroad. In Science, Technology & Innovation Indicators in the State of São Paulo/Brazil 2004, Chapter 6 (Coordinator, Eduardo Albuquerque).
24. Farrell, Joseph, Richard J. Gilbert, and Michael L. Katz. 2003. Market Structure, Organizational Structure, and R&D Diversity. In Richard Arnott et al., eds., Economics for an Imperfect World-Essays in Honor of Joseph E. Stiglitz. Cambridge, MA: MIT Press, 195-220.
25. Fink, Carsten. 2000. How Stronger Patent Protection in India Might Affect the Behavior of Transnational Pharmaceutical Industries. Policy Research Paper, The World Bank, no. 2352.
26. Gallini, Nancy T. 1992. Patent Policy and Costly Imitation. Rand Journal of Economics23: 52-63.
27. Gallini, Nancy T. 2002. The Economics of Patents: Lessons from Recent U.S. Patent Reform. Journal of Economic Perspectives 16: 131-54.
28. Geuna, Aldo, and Lionel Nesta. 2006. University Patenting and Its Effects onAcademic Research: The Emerging European Evidence. Research Policy 35(6): 790-807
29. Gilbert, Richard J., and David M. G. Newbery. 1982. Preemptive Patenting and the Persistence of Monopoly. American Economic Review 72(3): 514-26.
30. Grabowski, Henry, and John M. Vernon. 2000. Effective Patent Life in Pharmaceuticals. International Journal of Technology Management 19: 98-120.
31. Hall, Bronwyn H., and Rosemarie Ham Ziedonis. 2001. The Patent Paradox Revisited: An Empirical Study of Patenting in the U.S. Semiconductor Industry, 1979-1995. Rand Journal of Economics 32: 101-28.
32. Heller, Michael H., and Rebecca S. Eisenberg. 1998. Can Patents Deter Innovation? The Anticommons in Biomedical Research. Science 280: 698-701.
33. Helpman, Elhanan. 1993. Innovation, Imitation, and Intellectual Property Rights. Econometrica 61(6): 1247-80.
34. Henderson, Rebecca, Luigi Orsenigo, and Gary P. Pisano. 1998. The Pharmaceutical Industry and the Revolution in Molecular Biology: Exploring the Interactions between Scientific, Institutional and Organizational Change. In D. Mowery and R. Nelson, eds., The Sources of Industrial Advantages. Cambridge, MA: Cambridge University Press.
35. Horowitz, Andrew W., and Edwin L. C. Lai. 1996. Patent Length and the Rate of Innovation. International Economic Review 37: 785-801.
36. Huang, Hsin-Ting, and Marcela Miozzo. 2004. Patterns of Technological Specialisation in Latin American and East Asian Countries: An Analysis of Patents and Trade Flows. Economics Innovation New Technology 13(7): 615-53.
37. Jaffe, Adam B. 2000. The U.S. Patent System in Transition: Policy Innovation and the Innovation Process. Research Policy 29(4-5): 531-57.
38. Jaffe, Adam B., and Josh Lerner. 2004. Innovation and Its Discontents: How Our Broken Patent System is Endangering Innovation and Progress, and What to Do about It. Princeton: Princeton University Press.
39. Khan, B. Zorina, and Kenneth L.Sokoloff. 1998. Patent Institutions, Industrial Organization and Early Technological Change: Britain and the United States 1790-1850. In Maxine Berg, and Kristine Bruland, eds., Technological Revolutions in Europe: Historical Perspectives. Cheltenham, U.K.: Edward Elgar.
40. Kortum, Samuel, and Josh Lerner. 1998. Stronger Protection or Technological Revolution: What is Behind the Recent Surge in Patenting? Carnegie-Rochester Conference Series on Public Policy 48: 247-304.
41. Kumar, Nagesh. 1998. Technology Generation and Transfers in the World Economy: Recent Trends and Prospects for Developing Countries. In N. Kumar et al., eds., Globalization, Foreign Direct Investment and Technology Transfer: Impacts on and the Prospects for Developing Countries. London and New York: Routledge.
42. Kumar, Nagesh. 2002. Intellectual Property Rights, Technology and Economic Development: Experiences of Asian Countries. Paper Prepared for the Commission of Intellectual Property Rights (CIPR). London.
43. Lall, Sanjaya. 2003. Indicators of the Relative Importance of IPRs in Developing Countries. Research Policy 32: 1657-80.
44. Lamoreaux, Naomi R., and Kenneth L. Sokoloff. 1999. Inventive Activity and the Market for Technology in the United States, 1840-1920. NBER Working Papers Series, No. 7107.
45. Lanjouw, Jean O. 1998a. The Introduction of Pharmaceutical product Patents in India: Heartless Exploitation of the Poor and Suffering? NBER Working Papers Series,No. 6366.
46. Lanjouw, Jean O. 1998b. Patent Protection in the Shadow of Infringement: Simulation Estimations of Patent Value. The Review of Economic Studies 65: 671-710.
47. Lerner, Josh. 2002. 150 Years of Patent Protection. American Economic Review 92(2): 221-25.
48. Levin, Richard C., Alvin K. Klevorick, Richard R. Nelson, and Sidney G. Winter. 1987. Appropriating the Returns from Industrial Research and Development. Brookings Papers on Economic Activity (3): 783-820.
49. Lichtenberg, Frank R., and Tomas J. Philipson. 2002. The Dual Effects of Intellectual Property Regulations: Within-and Between-Patent Competition in the U.S. Pharmaceuticals Industry. The Journal of Law and Economics 45: 643-72.
50. Maskus, Keith. 2000. Lessons from Studying the International Economics of Intellectual Property Rights. Vanderbilt Law Review 53: 2219-39.
51. Maskus, Keith. 2001. Parallel Imports in Pharmaceuticals: Implications for Competition and Prices in Developing Countries. Final Report to World Intellectual Property Organization. Mazzoleni, Roberto, and Richard R. Nelson. 2000. Economic Theories about the Benefits and Costs of Patents. Journal of Economic Issues 32: 1031-52.
52. Merges, Robert P., and Richard R. Nelson. 1994. On Limiting or Encouraging Rivalry in Technical Progress: The Effect of Patent Scope Decisions. Journal of Economic Behavior and Organization 25: 1-24.
53. Montobbio, Fabio. 2007. Patenting Activity in Latin American and Caribbean Countries. In World Intellectual Property Organization (WIPO)-Economic Commission for Latin America and the Caribbean (ECLAC)-Study on Intellectual Property Management in Open Economies: A Strategic Vision for Latin America, http://eco.uninsubria.it/webdocenti/fmontobbio/cv/Montobbio2006wipo_draft.pdf.
54. Montobbio, Fabio, and Fancesco Rampa. 2005. The Impact of Technology and Structural Change on Export Performance in Developing Countries. World Development 33(4): 527-47.
55. Moser, Petra. 2005. How Do Patent Laws Influence Innovation? Evidence for 19th Century World Fairs. NBER Working Papers Series, No. 9909.
56. Mowery, David C., Richard R. Nelson, Bhaven N. Sampat, and Arvids Ziedonis. 2001. The Growth of Patenting and Licensing by U.S. Universities: An Assessment of the Effects of the Bayh-Dole Act of 1980. Research Policy 30: 99-119.
57. Murphy, Kevin M., Andrei Shleifer, and Robert W. Vishny. 1991. The Allocation of Talent: Implications for Growth. The Quarterly Journal of Economics 106(2): 503-30.
58. Murray, Fiona, and Scott Stern. Do Formal Intellectual Property Rights Hinder the Free Flow of Scientific Knowledge? An Empirical Test of the Anti-Commons Hypothesis. Journal of Economic Behavior & Organization, forthcoming.
59. Nightingale, Paul, and Paul Martin. 2004. The Myth of the Biotech Revolution. Trends in Biotechnology 22(11): 564-69.
60. Nogues, Julio J. 1993. Social Costs and Benefits of Introducing Patent Protection for Pharmaceutical Drugs in Developing Countries. The Developing Economies 31: 24-53.
61. Nordhaus, William D. 1969. Invention Growth, and Welfare: A Theoretical Treatment of Technological Change. Cambridge, MA: MIT Press.
62. OECD. 1994. The Measurement of Scientific and Technological Activities. Using Patent Data as Science and Technology Indicators-Patent Manual. OECD. Paris.
63. Orsenigo, Luigi, Fabio Pammolli, and Massimo Riccaboni. 2001. Technological Change and the Dynamics of Networks of Collaborative Relations. The Case of the Bio-pharmaceutical Industry. Research Policy 30: 485-508.
64. Orsenigo, Luigi, Mariana Mazzucato and Giovanni Dosi. 2006. The Dynamics of Knowledge Accumulation, Regulation and Appropriability in the Pharma-Biotech Sector: Policy Issues. In Giovanni Dosi, and Mariana Mazzucato, eds., Knowledge Accumulation and Industry Evolution: The Case of Pharma-Biotech. Cambridge, MA: Cambridge University Press.
65. Pavitt, Keith. 1988. Uses and Abuses of Patent Statistics. In A. F. J. Van Raan, ed., Handbook of Quantitative Studies of Science and Technology. Amsterdam: Elsevier Science Publishers.
66. Ramani, Shyama V., and Augustin Maria. 2005. TRIPS: Its Possible Impact on Biotech Segment of the Indian Pharmaceutical Industry. EPW Special Articles February 12-18: 675-83.
67. Sakakibara, Mariko, and Lee Branstetter. 2001. Do Stronger Patents Induce More Innovation? Evidence from the 1988 Japanese Patent Law Reforms. Rand Journal of Economics 32: 77-100.
68. Schankerman, Mark. 1998. How Valuable is Patent Protection? Estimates by Technology Field. Rand Journal of Economics 29(1): 77-107.
69. Scherer, F. M. 2001. The Link between Gross Profitability and Pharmaceutical R&D Spending. Health Affairs 20(5).
70. Scherer, F. M., and Sandy Weisburst. 1995. Economic Effects of Strengthening Pharmaceutical Patent Protection in Italy. International Review of Industrial Property and Copyright Law 6: 1009-24.
71. Scotchmer, Suzanne. 1991. Standing on the Shoulders of Giants: Cumulative Research and the Patent Law. Journal of Economic Perspectives 5(1): 29-41.
72. Stokes, Donald. 1997. Pasteur's Quadrant: Basic Science and Technological Innovation. Washington, DC: The Brookings Institution.
73. Thursby, Jerry G., and Marie C. Thursby. 2003. University Licensing under Bayh-Dole: What Are the Issues and Evidence? Emory University Working Paper., No. 13256.
74. Walsh, John P., Wesley M. Cohen, and Ashish Arora. 2003. Patenting and Licensing of Research Tools and Biomedical Innovation. In S. Merrill and M. Meyers, eds., Innovation in a Knowledge-Based Economy. Washington, DC: National Academies Press.
75. Watal, Jayashree. 2000. Pharmaceutical Patents, Prices and Welfare Losses: A Simulation Study of Policy Options for India under the WTO TRIPS Agreement. The World Economy 23: 733-52.